Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year?

Group 1 - Alpha Cognition Inc. (ACOG) is a stock that has gained attention for its performance compared to the Medical sector, with a year-to-date gain of 5.8% against the sector average of 4.9% [4] - ACOG is part of the Medical sector, which consists of 950 individual stocks and currently holds a Zacks Sector Rank of 4 [2] - The Zacks Rank for ACOG is 2 (Buy), indicating a positive outlook based on earnings estimates and revisions [3] Group 2 - Over the past 90 days, the Zacks Consensus Estimate for ACOG's full-year earnings has increased by 30.7%, reflecting improved analyst sentiment [4] - ACOG is categorized under the Medical - Biomedical and Genetics industry, which includes 468 companies and has an average gain of 16.5% this year, indicating ACOG is slightly underperforming its industry [6] - Another stock in the Medical sector, Actinium Pharmaceuticals (ATNM), has outperformed with a year-to-date return of 13.5% and a Zacks Rank of 2 (Buy) [5][6]